The US National Science Foundation (NSF) has launched an investment programme to advance scientific community datasets and enable innovation through AI. The programme is called NSF Unlocking Dataset ...
The comprehensive computational framework bridges generative deep-learning models with high-throughput experimental workflows to address structural bottlenecks in biopharmaceutical development, ...
2026 marks the symposium's 35th year covering separation sciences ...
Chai Discovery, an AI company developing a computer-aided design suite for molecules, is collaborating with Novartis to advance the discovery of therapeutic antibodies using AI Under the collaboration ...
AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on native Outer Membrane Vesicles (nOMVs), has published first-in-human Phase I clinical data ...
Beckman Coulter Diagnostics, a specialist in clinical diagnostics and a Danaher company, has received CE Mark under IVDR for its Acess p-Tau217 assay, a blood test designed to support the clinical ...
Osteosarcoma is an aggressive bone cancer characterised by high rate of recurrence and metastasis. It is the most common primary bone cancer in children, adolescents and young adults. Symptoms include ...
CDMO partner Freudenberg Medical recently launched CleanAssure, an ISO Class 5 controlled cleanroom for sterile single-use assemblies. The cleaning and sterilisation service supports biopharmaceutical ...
A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...
Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...
Waters Corporation has launched a the Xevo MRT P10 mass spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) system for high-throughput multiomics, bioanalysis and biopharmaceutical ...
Women’s health medical technology company Calla Lily Clinical Care has dosed the first patients in the Freedom clinical trial. The study is evaluating 400mg progesterone Callavid in patients diagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results